COVID-19 and hypercoagulability in the outpatient setting
- PMID: 32473495
- PMCID: PMC7245205
- DOI: 10.1016/j.thromres.2020.05.031
COVID-19 and hypercoagulability in the outpatient setting
Keywords: COVID-19; Coronavirus; Hypercoagulable; Pulmonary embolism; Venous thromboembolism.
Conflict of interest statement
Declaration of competing interest Dr. Zampella is a consultant for X4 Pharmaceuticals.
Comment on
-
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6. J Thromb Haemost. 2020. PMID: 32271988 Free PMC article.
References
-
- Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V., Pesenti A., Peyvandi F., Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020 doi: 10.1111/jth.14850. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
